Aller au contenu principal
Profil bibliographique

Paraskevi Kousteridou

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées
34Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Cancer, Hypoxia, and MetabolismHistone Deacetylase Inhibitors ResearchPolyamine Metabolism and ApplicationsProtein Degradation and InhibitorsPancreatic and Hepatic Oncology Research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Hypusination of the translation factor eIF5A regulates mitochondrial tRNA processing to promote prostate cancer aggressiveness

Michel Kahi, Abigail Mazzu′, Ludovic Batistic, Marc Pujalte-Martin et autres

Protein synthesis plays a central role in cancer development and progression. eukaryotic initiation factor 5 A (eIF5A), a translation factor activated by hypusination, is implicated in tumorigenesis, however, its mode of action is still unclear. We find that hypusinated eIF5A (eIF5Ahyp) promotes …

fr, nl, in, us (code pays fourni par la source)

1 citation Nature Communications
Accès ouvert 2025 article OpenAlex

The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage

Georgios Efthymiou, E.R.M.A. Lohmann, Claudio Montenegro, Paraskevi Kousteridou et autres

The excessive production of extracellular matrix (ECM) and the metabolic adaptations in pancreatic ductal adenocarcinoma (PDAC) contribute individually to enhanced chemoresistance, marked tumor progression, and dismal patient survival. However, ECM-driven metabolic alterations that promote chemoresistance in PDAC are so far unexplored. Here, …

fr, br, us (code pays fourni par la source)

6 citations Science Advances
Accès ouvert 2025 article OpenAlex

Dual targeting of CDK6 and LSD1 is synergistic and overcomes differentiation blockade in AML

Lise M. Brault, Edwige Voisset, Mathieu Desaunay, Antonia Boudet et autres

The heterogeneity of leukemic cells is the main cause of resistance to therapy in acute myeloid leukemia (AML). Consequently, innovative therapeutic approaches are critical to target a wide spectrum of leukemic clones, regardless of their genetic and non-genetic complexity. In this report, …

fr, us (code pays fourni par la source)

2 citations EMBO Molecular Medicine
Accès ouvert 2025 article OpenAlex

The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active

Celia Sequera, Margherita Grattarola, Floriane Cannet, Aurélie Dobric et autres

Histone deacetylases (HDACs) are epigenetic regulators frequently altered in cancer. Here we report that overexpression of HDAC1/2 occurs in Hepatocellular Carcinoma (HCC) patients, correlating with poor prognosis. We show that romidepsin, a class-I HDAC inhibitor, elicits a combinatorial perturbation of distinct molecular …

fr, us, ch, it (code pays fourni par la source)

18 citations Nature Communications
Accès ouvert 2025 article OpenAlex

Comparative impact of proton versus photon irradiation on triple‐negative breast cancer: Role of VEGFC in tumour aggressiveness

Saharnaz Sarlak, D. Marotte, Jessy Sirera, Arthur Karaulic et autres

Dear Editor,In this study, we demonstrated that proton (P) and photon (X) radiotherapies (RT) lead to different molecular changes in triple-negative breast cancer (TNBC) cells.Pirradiated tumours tended to make larger tumours, while X-irradiated ones exhibited increased aggressiveness.Both types of radiation increased gene …

fr (code pays fourni par la source)

0 citations Clinical and Translational Medicine
Accès ouvert 2025 preprint OpenAlex

The extracellular matrix drives guanylate production and protects pancreatic cancer cells from oxaliplatin-induced DNA damage

Georgios Efthymiou, Coralie Compare, Eugénie Lohmann, Paraskevi Kousteridou et autres

Abstract The excessive production of extracellular matrix (ECM) and the metabolic adaptations in pancreatic ductal adenocarcinoma (PDAC) contribute individually to enhanced chemoresistance, dramatic tumor progression and dismal patient survival. However, ECM-driven metabolic alterations that promote chemoresistance in PDAC are so far unexplored. …

fr, us (code pays fourni par la source)

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2021 article OpenAlex

GlcNAc is a mast-cell chromatin-remodeling oncometabolite that promotes systemic mastocytosis aggressiveness

Julie Agopian, Quentin Da Costa, Quang Vo Nguyen, Giulia Scorrano et autres

Systemic mastocytosis (SM) is a KIT-driven hematopoietic neoplasm characterized by the excessive accumulation of neoplastic mast cells (MCs) in various organs and, mainly, the bone marrow (BM). Multiple genetic and epigenetic mechanisms contribute to the onset and severity of SM. However, little …

fr, us, nl, es (code pays fourni par la source)

6 citations Blood

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.